Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alexia Patroni"'
Autor:
Jérôme Alexandre Denis, Alexia Patroni, Erell Guillerm, Dominique Pépin, Naoual Benali-Furet, Janine Wechsler, Gilles Manceau, Maguy Bernard, Florence Coulet, Annette K. Larsen, Mehdi Karoui, Jean-Marc Lacorte
Publikováno v:
Molecular Oncology, Vol 10, Iss 8, Pp 1221-1231 (2016)
In colorectal cancer (CRC), KRAS mutations are a strong negative predictor for treatment with the EGFR‐targeted antibodies cetuximab and panitumumab. Since it can be difficult to obtain appropriate tumor tissues for KRAS genotyping, alternative met
Externí odkaz:
https://doaj.org/article/c3706c07b9d94c6ca64428ed30c982ae
Publikováno v:
Colorectal Disease. 19:O377-O385
Aim To assess the prognostic influence of the circumferential resection margin (CRM) exact value after total mesorectal excision (TME) for mid or low rectal cancer. Methods All patients (n=321), who underwent TME from 2005 and 2013 where identified f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c89677005fd7f5470455df4c7db67c26
https://doi.org/10.1111/codi.13895
https://doi.org/10.1111/codi.13895
Publikováno v:
Soins. Gerontologie. 23(132)
Colorectal cancer risk factors increase with age, comorbidities, delayed diagnosis, obstruction, emergency and frailty. Surgery is the standard treatment as the survival rate for this pathology is the same as in young patients. It would appear that t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::239ceb05e2d9638f20eaef6f1df8787d
https://pubmed.ncbi.nlm.nih.gov/30522760
https://pubmed.ncbi.nlm.nih.gov/30522760
Publikováno v:
Soins Gérontologie. 23:24-25
Colorectal cancer risk factors increase with age, comorbidities, delayed diagnosis, obstruction, emergency and frailty. Surgery is the standard treatment as the survival rate for this pathology is the same as in young patients. It would appear that t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e3b7b235fda34f8ee965986472e8268
https://doi.org/10.1016/j.sger.2018.05.007
https://doi.org/10.1016/j.sger.2018.05.007
Autor:
Alexia Patroni, Janine Wechsler, Erell Guillerm, Maguy Bernard, Jean-Marc Lacorte, Mehdi Karoui, Florence Coulet, Jérôme Alexandre Denis, Naoual Benali-Furet, Gilles Manceau, Annette K. Larsen, Dominique Pepin
Publikováno v:
Molecular Oncology
Molecular Oncology, Elsevier, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
Molecular Oncology, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
Molecular Oncology, Elsevier, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
Molecular Oncology, 2016, 10 (8), pp.1221-1231. ⟨10.1016/j.molonc.2016.05.009⟩
International audience; In colorectal cancer (CRC), KRAS mutations are a strong negative predictor for treatment with the EGFR-targeted antibodies cetuximab and panitumumab. Since it can be difficult to obtain appropriate tumor tissues for KRAS genot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e6cba3d36fcb1ee0ea74524ae0b3bf
https://hal.sorbonne-universite.fr/hal-01331243
https://hal.sorbonne-universite.fr/hal-01331243
